{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:59:27Z","timestamp":1768568367713,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Vitiligo is a skin disorder characterized by the loss of melanocytes from the epidermis. Cysteine x cysteine motif chemokine ligand 10 (CXCL10) is linked to the Th1 pattern and has been suggested as one of the most relevant chemokine axes that promote T-cell migration in different autoimmune and inflammatory processes. The aim of this study was to assess the immunohistochemical (IHC) expression of CXCL 10 in skin lesions of patients with vitiligo to explore its possible role in the pathogenesis of the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this prospective, case-control study, we examined biopsies from the lesional skin of 20 patients with vitiligo for IHC expression of CXCL 10: 10 patients presented with stable nonsegmental vitiligo (group A), 10 patients presented with active nonsegmental vitiligo (group B), and 10 apparently healthy volunteers were examined as controls (group C).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nine patients in group A had mild IHC expression of CXCL 10 (+1) and 1 patient had moderate expression (+2). In group B, 8 patients had strong expression of CXCL 10 (+3), and the remaining patients had moderate expression (+2). However, there was no expression of CXCL 10 in all skin specimens in the control group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>CXCL10 IHC expression was increased in vitiligo lesions indicating a possible role in the pathogenesis of disease. The expression was significantly increased in active vitiligo compared with stable vitiligo.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dad.0000000000002774","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T23:00:15Z","timestamp":1726614015000},"page":"734-738","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Immunohistochemical Expression of CXCL 10 in Vitiligo"],"prefix":"10.1097","volume":"46","author":[{"given":"Asmaa Omar","family":"Abdelmonem","sequence":"first","affiliation":[{"name":"Dermatology and Venereology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany Mohammad","family":"Abdel-Latif","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dareen Abdulaziz","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada Fawzy","family":"Rezk Hassan","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"102932","DOI":"10.1016\/j.autrev.2021.102932","article-title":"Autoimmunity in vitiligo: therapeutic implications and opportunities","volume":"21","author":"Khaitan","year":"2022","journal-title":"Autoimmun Rev."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1038\/s41598-017-10253-w","article-title":"Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligo","volume":"7","author":"Singh","year":"2017","journal-title":"Sci Rep."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","article-title":"Vitiligo pathogenesis and emerging treatments","volume":"35","author":"Rashighi","year":"2017","journal-title":"Dermatol Clin."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","article-title":"Update on the pathogenesis of vitiligo","volume":"97","author":"Marchioro","year":"2022","journal-title":"Bras Dermatol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/bjd.15550","article-title":"Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis","volume":"177","author":"Jacquemin","year":"2017","journal-title":"Br J Dermatol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.autrev.2017.07.006","article-title":"Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis","volume":"16","author":"Ferrari","year":"2017","journal-title":"Autoimmun Rev."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/pcmr.12667","article-title":"CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: a multicenter cross-sectional study","volume":"31","author":"Abdallah","year":"2018","journal-title":"Pigment Cel Melanoma Res."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21608\/ejmr.2022.216156","article-title":"Study of detection of serum CXCL10 in vitiligo patients","volume":"3","author":"El-Rifaie","year":"2022","journal-title":"Egypt J Med Res."},{"key":"R10-20250616","first-page":"1514","article-title":"The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology","volume":"135","author":"Njoo","year":"1999","journal-title":"Arch Dermatol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0378-6323.26722","article-title":"Scoring systems in dermatology","volume":"72","author":"Bhor","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1038\/s41598-019-44032-6","article-title":"Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8\/A9 in lymph nodes of patients with adult-onset Still's disease","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/ijd.ijd_11_22","article-title":"Assessment of CXCL10 before and after narrow band UVB phototherapy in non-segmental vitiligo patients","volume":"67","author":"Hussein","year":"2022","journal-title":"Indian J Dermatol."},{"key":"R14-20250616","first-page":"e29307","article-title":"Vitiligo: a narrative review","volume":"14","author":"Joge","year":"2022","journal-title":"Cureus"},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/imm.12399","article-title":"Human Th1 dichotomy: origin, phenotype and biologic activities","volume":"144","author":"Annunziato","year":"2014","journal-title":"Immunology"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/1346-8138.14004","article-title":"Role of chemokines and the corresponding receptors in vitiligo: a pilot study","volume":"45","author":"Yang","year":"2018","journal-title":"J Dermatol."},{"key":"R17-20250616","first-page":"27","article-title":"Chemokines in vitiligo pathogenesis: CXCL10 and 12","volume":"14","author":"Gharib","year":"2021","journal-title":"J Clin Aesthet Dermatol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jdermsci.2018.12.005","article-title":"Circulating CCL20: a potential biomarker for active vitiligo together with the number of Th1\/17 cells","volume":"93","author":"Zhang","year":"2019","journal-title":"J Dermatol Sci."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med."},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"1112811","DOI":"10.3389\/fimmu.2023.1112811","article-title":"A meta-analysis of chemokines in vitiligo: recruiting immune cells towards melanocytes","volume":"14","author":"Speeckaert","year":"2023","journal-title":"Front Immunol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:03:39Z","timestamp":1750097019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002774","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,17]]}}}